Genital Warts: Men Need To Be Concerned Too

Only females can die from cervical cancer. Perhaps that is the reason why there has been so much recent emphasis and debate on producing and mandating a vaccine to prevent girls from acquiring the virus which causes the genital warts. Perhaps it is also the reason why most talk about irresponsible sexual activity is generally focused on girls and women. Where there is less focus, however, is that males can be equally responsible in preventing genital warts in themselves. Males can avoid contracting these warts, and can also avoid passing them on if they do become infected.

Given the status of American society today, it should not be surprising that for males as well as females the focus is not on conducing oneself in a responsible manner, but to take preventive measures while continuing risky behavior. Although males generally have much less chance of genital warts leading to life-threatening illnesses, studies show an average of an eighty-percent risk of acquiring genital warts during their lifetimes.

Studies rarely add that the primary risk factor is that of having numerous sexual partners. In that genital warts in men rarely lead to serious health conditions in themselves, the main concern is to not infect their partners with these warts.

One of the most recent studies on the subject of these warts has been by the Medical College of Georgia. The goal of these studies has been to perfect a vaccine made especially for men. The concept behind these studies was that even though men do not usually have life-threatening risks from warts, transmitting the infection to their partners is reason enough to take the issue seriously. Preventing males from acquiring any of the four strains of the virus which cause these warts would in turn prevent outbreaks of warts. This in turn would ensure the safety of their partners.

Although the Medical College of Georgia began its studies into the possibility of such a vaccine a number of years ago, at last check there have been no conclusive results. The College had been seeking test-subjects who had not yet developed genital warts. They were specifically looking for sexually-active males who were between the ages of sixteen and twenty-three, to participate in these research studies.

But while the Medical College of Georgia was also responsible for the largest similar research on this vaccine in women, the vaccine has not only been approved for but distributed to girls, while the vaccine for males has not been. As both males and females are susceptible to this virus, it would seem that preventing both from acquiring genital warts should be the same priority.

As those who have been conducting this research have lacked this priority, it leaves the subject of responsible conduct in the hands of men themselves.